This information is intended only for healthcare professionals resident in the Great Britain

Prescribing Information (PI) for Abrysvo®▼ (Respiratory syncytial virus vaccine [bivalent, recombinant]) Great Britain (GB) and Northern Ireland (NI)

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Abrysvo (Respiratory syncytial virus vaccine [bivalent, recombinant]) powder and solvent for solution for injection - PI for GB

Northern Ireland

  • Abrysvo (Respiratory syncytial virus vaccine [bivalent, recombinant]) powder and solvent for solution for injection - PI for NI

Abrysvo (Respiratory syncytial virus vaccine [bivalent, recombinant]) powder and solvent for solution for injection - PI for GB

Abrysvo (Respiratory syncytial virus vaccine [bivalent, recombinant]) powder and solvent for solution for injection - PI for NI

PP-A1G-GBR-0050 February 2024